Contribution of Oncogenetics in Breast Cancer in Reunion Epidemiology of Breast Cancer in Reunion: Study of the Reunion Mutation on BRCA2

Not Applicable

Recruiting

• Conditions: Breast Cancer; Genetic Disease; BRCA2 Mutation

• Registration Number: NCT05898009
• Lead Sponsor: Centre Hospitalier Universitaire de la Réunion

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-6-1
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Inclusion Criteria:<br><br> - Domiciled in Reunion at the time of the diagnosis<br><br> - Who is diagnosed with a first breast cancer (in situ or invasive) confirmed by<br> anatomopathological examination during the inclusion period Or Who is diagnosed with<br> a second breast cancer (in situ or invasive) confirmed by pathological examination<br> during the inclusion period, contralateral to the first or at least 5 years after<br> remission of the first<br><br> - Having agreed to participate in the study;<br><br> - Affiliates or beneficiaries of a social security scheme<br><br>Exclusion Criteria:<br><br> - Carriers of breast lymphoma,<br><br> - Minor patients or patients under guardianship or curatorship

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
determine the prevalence of the Réunion mutation in the BRCA2 gene (c.2612C>A mutation of exon 11) in the population of individuals residing in Réunion who are diagnosed with breast cancer.